Tess V Clendenen

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. doi request reprint Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Division of Epidemiology, New York, NY 10016, USA
    J Magn Reson Imaging 38:474-81. 2013
  2. pmc Genetic variants in hormone-related genes and risk of breast cancer
    Tess Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 8:e69367. 2013
  3. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
  4. doi request reprint Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
  5. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
  6. pmc Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
  7. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
  8. pmc Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
  9. pmc Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 10:e0140478. 2015
  10. pmc Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle
    Alana R Amarosa
    Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, 660 First Ave, 4th Floor, New York, NY 10016, USA
    Radiology 268:356-65. 2013

Detail Information

Publications14

  1. doi request reprint Comparison of 3-point Dixon imaging and fuzzy C-means clustering methods for breast density measurement
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Division of Epidemiology, New York, NY 10016, USA
    J Magn Reson Imaging 38:474-81. 2013
    ..To assess two methods of fat and fibroglandular tissue (FGT) segmentation for measuring breast MRI FGT volume and FGT%, the volume percentage of FGT in the breast, in longitudinal studies...
  2. pmc Genetic variants in hormone-related genes and risk of breast cancer
    Tess Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 8:e69367. 2013
    ..Our results suggest that these genetic variants do not have a strong effect on breast cancer risk. ..
  3. pmc Circulating prolactin levels and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, NY, USA
    Cancer Causes Control 24:741-8. 2013
    ..Indirect evidence from experimental and epidemiological studies suggests that prolactin may be involved in ovarian cancer development. However, the relationship between circulating prolactin levels and risk of ovarian cancer is unknown...
  4. doi request reprint Magnetic resonance imaging (MRI) of hormone-induced breast changes in young premenopausal women
    Tess V Clendenen
    New York University School of Medicine, Department of Environmental Medicine, Divison of Epidemiology, New York, NY 10016, USA
    Magn Reson Imaging 31:1-9. 2013
    ..We conducted a pilot study to identify whether MRI parameters are sensitive to hormone-induced changes in the breast during the natural menstrual cycle and whether changes could also be observed during an oral contraceptive (OC) cycle...
  5. pmc Factors associated with inflammation markers, a cross-sectional analysis
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cytokine 56:769-78. 2011
    ..Our findings suggest that risk factors for chronic diseases (age, BMI, menopausal status, parity, NSAID use, family history of breast and ovarian cancer, and smoking) are associated with inflammation markers in healthy women...
  6. pmc Temporal reliability of cytokines and growth factors in EDTA plasma
    Tess V Clendenen
    Department of Environmental Medicine, New York University Langone Medical Center, New York, NY, USA
    BMC Res Notes 3:302. 2010
    ..Cytokines are involved in the development of chronic diseases, including cancer. It is important to evaluate the temporal reproducibility of cytokines in plasma prior to conducting epidemiologic studies utilizing these markers...
  7. pmc Circulating inflammation markers and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York, NY, USA
    Cancer Epidemiol Biomarkers Prev 20:799-810. 2011
    ..The purpose of this study was to assess the association between circulating levels of inflammation mediators and subsequent risk of ovarian cancer...
  8. pmc Circulating vitamin d and risk of epithelial ovarian cancer
    Alan A Arslan
    Department of Environmental Medicine, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA
    J Oncol 2009:672492. 2009
    ..59-2.01). In addition, there was no evidence of an interaction effect between VDR SNP genotype or haplotype and circulating 25(OH)D levels in relation to ovarian cancer risk, although more complex gene-environment interactions may exist...
  9. pmc Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 10:e0140478. 2015
    ..These results, combined with the observation in this cohort and most other prospective studies of no association of circulating 25(OH)D with breast cancer risk, do not support an association between vitamin D and breast cancer risk. ..
  10. pmc Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle
    Alana R Amarosa
    Department of Radiology, Center for Biomedical Imaging, New York University School of Medicine, 660 First Ave, 4th Floor, New York, NY 10016, USA
    Radiology 268:356-65. 2013
    ....
  11. pmc Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer
    Tess V Clendenen
    Division of Epidemiology, Department of Environmental Medicine, New York University School of Medicine, 650 First Avenue, 5th Floor, New York, NY 10016 3240, USA
    Cancer Epidemiol Biomarkers Prev 18:275-81. 2009
    ..Our results suggest that endogenous estrone is associated with increased risk of colorectal cancer in postmenopausal women...
  12. pmc Estimation and selection of complex covariate effects in pooled nested case-control studies with heterogeneity
    Mengling Liu
    Departments of Population Health and Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Biostatistics 14:682-94. 2013
    ..We conduct simulation studies to evaluate the performance of our proposed approaches in finite samples under various heterogeneity settings, and apply them to the pooled ovarian cancer study...
  13. pmc Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer
    Tess V Clendenen
    Department of Environmental Medicine, New York University School of Medicine, New York, NY 10016, USA
    Cancer Lett 260:209-15. 2008
    ..These observations do not support a role for BSMI, APAI, TAQI, and FOKI polymorphisms in epithelial ovarian cancer in a predominantly Caucasian population...
  14. pmc Genotyping of Single Nucleotide Polymorphisms in DNA Isolated from Serum Using Sequenom MassARRAY Technology
    Tess V Clendenen
    Department of Population Health, New York University School of Medicine, New York, New York, United States of America
    PLoS ONE 10:e0135943. 2015
    ..Some of these studies, however, have only serum or plasma samples as a low quantity source of DNA...